Objective-Inflammatory infiltrates and atherosclerotic lesions emerge when monocytes adhere to endothelial cells (ECs), migrate into the subendothelial space, and become macrophages (M⌽s). Leukotrienes (LTs), products of 5-lipoxygenase, are powerful inflammatory mediators. 5-lipoxygenase ϩ M⌽s have been shown to increase during atherogenesis, and LT receptor (LT-R) transcripts were identified in diseased arteries. To investigate LT-Rs in cells involved in inflammation and atherogenesis, we used the in vitro models of human umbilical vein ECs (HUVECs) and monocyte-derived M⌽s. Methods and Results-HUVECs primarily expressed transcripts of the cysteinyl (cys) LT 2 -R, which was strongly upregulated by interleukin-4. By contrast, M⌽s predominantly expressed transcripts of the cysLT 1 -R. Calcium responses toward LTs revealed differential cysLT-R utilization by both cell types: HUVECs responded to both cysLTs, whereas M⌽s preferentially responded to LTD 4 ; HUVECs, but not M⌽s, were resistant toward a cysLT 1 -R antagonist, montelukast; cysLTs generated regular calcium oscillations in HUVECs that lasted Ͼ60 minutes, resulting in Ͼ500 oscillations per cell. By contrast, calcium elevations in M⌽s returned to baseline within seconds and were nonoscillatory.
LTD 4 , and LTE 4 , are potent, proinflammatory mediators. 1, 2 Four LT-activated, putative, 7 transmembrane G protein-coupled receptors have been characterized: 2 receptors for LTB 4 , namely BLT-Rs, 3, 4 and 2 receptors for LTD 4 and LTC 4 , namely, cysLT-Rs. 5, 6 Whereas LTB 4 mediates chemotaxis, 3 cysLTs trigger a variety of tissue responses, including increases in vascular permeability. 7 CysLT 1 -R is primarily present in the spleen, blood leukocytes, and lung macrophages (M⌽s), 5 whereas cysLT 2 -R is expressed in the heart and brain. 6 However, the precise cell lineage-specific expression of LT-Rs, their mode of regulation, and the signaling pathways that they trigger remain to be determined.
We observed transcripts of all 4 LT-Rs in human atherosclerotic lesions. 8 These data raised the possibility that the 5-lipoxygenase (5-LO) pathway forms foci of inflammation within the arterial wall. Because human umbilical vein endothelial cells (HUVECs) and M⌽s have been used to study inflammation and recent studies have associated the 5-LO pathway with experimental atherosclerosis, 9 -15 we examined their LT-R expression patterns and characterized their calcium responses. fura 2-AM, from Calbiochem; fluo 4-AM, from Molecular Probes; transforming growth factor-␤1 (TGF ␤-1), interleukin-1␤ (IL-1␤), tumor necrosis factor-␣ (TNF-␣), and IL-4, from R&D Systems; LTs, from Cayman Chemicals; CD14 MicroBeads, from Miltenyi Biotech; and other reagents, from Sigma. Monocytes were purified from peripheral blood mononuclear cells by adherence or CD14 microbead adsorption and maintained at 1ϫ10 6 cells/mL for 5 to 9 days in RPMI-1640 medium plus 20% autologous human serum. HUVECs were cultured as described 16 and used at passages 1 to 2. Carotid artery disease lesions were obtained after informed consent of the patients, as described. 8 HUVECs or M⌽s were loaded with fura 2-AM at 4 mol/L, and changes in calcium ions were expressed as excitation ratios of 340 nm/380 nm at 510 nm. For single-cell measurements, cells were loaded with 2 mol/L fluo 4-AM. Responses were recorded on a microscope (Axiovert 200M) equipped with a confocal laser scanning head (LSM510). Quantitative (realtime) reverse transcription-polymerase chain reaction (qRT-PCR) was performed as previously reported. 8
Results

Expression Patterns of LT-R Transcripts in HUVECs and M⌽s
Determination of sequence-confirmed RT-PCR products of LT-Rs in HUVECs and M⌽s indicated differential expression of transcript levels. Preliminary, nonquantitative RT-PCR analyses indicated that HUVECs showed significant cysLT 2 -R and detectable BLT 1 -R and BLT 2 -R but no or low cysLT 1 -R transcripts. By contrast, M⌽s preferentially expressed cysLT 1 -R transcripts and, to a lesser extent, cysLT 2 -R, BLT 1 -R, and BLT 2 -R transcripts (Figure 1a ). qRT-PCR demonstrated the magnitude of differential LT-R transcript expression in both cell types (when expressed as absolute transcripts/10 5 glyceraldehyde 3-phosphate dehydrogenase [GAPDH] transcripts): HUVECs expressed cysLT 2 -Rs in large excess when compared with cysLT 1 -Rs (cysLT 2 -Rs, 983Ϯ527; cysLT 1 -R, 3Ϯ3; nϭ6). By contrast, M⌽s expressed cysLT 1 -Rs in large excess when compared with cysLT 2 -Rs (cysLT 1 -Rs, 6754Ϯ4507; cysLT 2 -R, 156Ϯ123; nϭ8). Interestingly, carotid artery disease lesions that represent advanced atherosclerotic lesions (type V) according to the American Heart Association nomenclature 8 expressed cysLT 1 -Rs that were only 3-fold higher than cysLT 2 -Rs (cysLT 1 -R, 439Ϯ158; cysLT 2 -R, 129Ϯ53; nϭ5). The numbers represent meanϮSD and are highly significant: PϽ0.01 for cysLT 1 R versus cysLT 2 R in HUVECs and M⌽s. These data show that HUVECs expressed cysLT 2 -R transcripts at Ͼ2 orders of magnitude higher levels when compared with cysLT 1 -R transcripts.
Cytokines implicated in inflammation and atherogenesis were examined for regulation of cysLT 2 -R transcripts. IL-4, but not IL-1␤, TGF-␤1, or TNF-␣ ( Figure 1b ), caused upregulation of cysLT 2 -R transcripts in a concentration-and time-dependent way (Figure 1c and 1d ). Confluent HUVECs expressed Ϸ2-fold higher numbers of cysLT 2 -R transcripts when compared with their rapidly proliferating counterparts (Figure 1d , open columns). Because both IL-4 and cell density contributed to cysLT 2 -R transcript upregulation in an additive way, this amounted to a 7-fold increase at 48 and 72 hours. Moreover, levels of cysLT 2 -R transcript decreased with increasing passage numbers. HUVECs were seeded at 1 to 2ϫ10 4 cells/cm 2 and maintained for 3 days until they reached subconfluence. Cells were stimulated with IL-4 at 50 ng/mL; TGF-␤1 at 5 ng/mL; IL-1␤ at 100 U/mL, and TNF-␣ at 100 U/mL for 24 hours (b); increasing concentrations of IL-4 for 48 hours (c); or 10 ng/mL IL-4 for increasing 
Calcium Responses Indicate Differential cysLT-R Utilization by HUVECs and M⌽s
In receptor-transfected cells, cysLT 1 -R has been shown to bind LTC 4 with lower affinity than LTD 4 , whereas the cysLT 2 -R binds LTC 4 and LTD 4 with similar affinities, but functional studies of cysLT 1 -R versus cysLT 2 -R in HUVECs have not yet been reported. 5, 6 Initially, calcium responses toward LTC 4 /LTD 4 of HUVECs and M⌽s were examined. LTC 4 or LTD 4 (50 nmol/L) triggered robust calcium rises with similar potencies in HUVECs, whereas the selective cysLT 1 -R antagonist montelukast (Singulair) failed to inhibit calcium transients (Figure 2a and 2b) . Moreover, BAY u9773, a partial cysLT 2 -R agonist, 17 induced a moderate response (Figure 2b) . By contrast, 50 nmol/L LTD 4 triggered robust calcium responses in M⌽s, whereas LTC 4 at 50 nmol/L was inactive, and LTD 4 -dependent calcium responses were completely blocked by montelukast (Singulair; Figure  2c ). These data are consistent with and extend studies reported by others that cysLTs cause calcium elevations in cultured HUVECs and M⌽s. 18 -20 Thus, our data demonstrate for the first time that the dominant, functional cysLT-R in HUVECs is the cysLT 2 -R. They establish HUVECs as a culture system in which selective activation of the cysLT 2 -R for the biology of ECs can be studied.
Calcium Elevations in HUVECs and M⌽s Reveal Differences in Kinetics, Amplitude, Duration, and Oscillatory Patterns
We noted that the initial rise of calcium ions in HUVECs was followed by a pronounced, sustained component, whereas that in M⌽s rapidly returned to near-baseline levels within seconds (compare Figure 2a, 2b, and 2c) . We next determined calcium responses in single cells. In HUVECs, the rapid initial LTC 4 /D 4 -dependent rise in calcium ions was followed by oscillations that, once established, proceeded at regular intervals (Figure 2d) . These data confirmed studies by Datta et al, 18 who demonstrated that cysLTs trigger oscillatory calcium rises in HUVECs. By contrast, in M⌽s, LTD 4 induced an initial increase in calcium ions, which rapidly returned to baseline levels (Figure 2e ) and was only rarely followed by single or irregular oscillations. These data show that oscillations are not invariably associated with the action of LTs on target cells, although they appear to depend on both the LT-R subtype and/or the target cell. We next initiated more detailed studies of the pharmacology, LT-R dependence, regularity, duration, intracellular location, variability, and dependence on culture conditions of oscillations in HUVECs. The frequency of oscillations did not vary considerably in individual HUVECs for extended periods of time, Figure 2 . Pharmacologic profiles of cysLT-dependent calcium transients in HUVECs and M⌽s and determination of calcium in single cells. Cells loaded with fura-2 were stimulated with agonists, montelukast (Singulair), or ethanol as indicated, and calcium transients were determined as described in Methods (a-c). Changes in fura-2 fluorescence (a-c) are expressed as fluorescence ratios and normalized to the scale indicated in a. Cells were loaded with fluo-4: an HUVEC (d) or an M⌽ (e) was examined during the initial Ca 2ϩ response. An HUVEC was examined during 2 oscillations after the initial rise of calcium ions in response to 1 mol/L LTC 4 had occurred and scanned at 1.79-second intervals (f); an M⌽ was examined after addition of 500 nmol/L LTD 4 (g) and scanned at 1.58-second intervals. 2.5D (upper row in f) and 2D (lower row in f) scans reveal an HUVEC cytosolic calcium puff close to the nucleus (arrow) that spreads into a calcium wave to encompass the nucleus within Ͻ2 seconds. Data are representative of at least 3 independent experiments.
although variability was noted between individual HUVECs. LT-dependent oscillations in HUVECs originated in subcellular areas in the cytoplasm (Figure 2f , arrow). Increases in calcium occurred in both the cytosol and the nucleus, whereby the nucleus was affected secondary to cytoplasmic calcium waves (Figure 2f ). Once generated in one EC, cysLT-triggered calcium waves appeared to be transferred to other ECs, thus generating global intercellular calcium waves, probably through gap junctions. This interpretation was supported by inspection of slow-motion recordings of oscillations across intact portions of the monolayer that revealed areas of ECs in which coordinated calcium oscillations that originated in calcium "puffs" of a single EC were observed. Importantly, calcium oscillations were a response to cysLT 2 -R activation, because montelukast failed to eliminate them (not shown). Moreover, calcium oscillations were dependent on extracellular calcium, because EGTA did not prevent the initial rise in calcium ions but led to an immediate cessation of ongoing oscillations. Culture parameters also influenced characteristics of calcium oscillations: a higher percentage of early-passage HUVECs responded to low concentrations of cysLTs when compared with higher-passage HUVECs, and this response was correlated with cysLT 2 -R transcripts; the frequency of oscillations was correlated with the concentration of the agonist. At 1 mol/L LTC 4 , the oscillation periods of HUVECs persisted for Ͼ60 minutes, resulting in Ͼ500 oscillations/h per HUVEC, whereas the response to another G proteincoupled receptor agonist, thrombin, was short-lived and subsided within seconds.
Discussion
HUVECs principally expressed cysLT 2 -Rs, which were upregulated 7-fold by a combination of IL-4 and cell density (Figure 1) . By contrast, HUVECs did not express significant numbers of cysLT 1 -Rs (Figures 1a, 2a, and 2b ), yet M⌽s principally expressed cysLT 1 -Rs (Figures 1a and 2c ). Because selective cysLT 2 -R antagonists are not yet available, these data establish HUVECs as the first bona fide cell system in which the signaling pathway of the cysLT 2 -R can be studied without interfering with cysLT 1 -R-dependent signaling. The cysLT-R expression patterns in HUVECs and M⌽s yielded calcium transients with very different properties: HUVECs and M⌽s differed in their sensitivities toward LTC 4 and LTD 4 ( Figure 2 ); response to LT-R antagonists; kinetics, regularity, and duration of calcium increases; and oscillatory versus nonoscillatory patterns.
When previous and the present data on expression of the 5-LO pathway and LT-Rs in ECs, M⌽s, and advanced human atherosclerotic lesions are considered, our data raise the possibility that leukocyte/EC/T-cell interactions might constitute inflammatory "circuits" through at least 2 major mechanisms: M⌽-derived LTs might activate cysLT 1 -Rs via autocrine mechanisms and EC cysLT 2 -Rs and T-lymphocyte cysLT 1 -Rs, via paracrine mechanisms during physiologic leukocyte trafficking, inflammation, and atherogenesis (Figure 3) . 
